Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study.

Rimegepant is a medication used to treat acute migraine attacks. This study looked at how well rimegepant works over multiple migraine events. Researchers followed 191 participants who experienced up to four different migraines. Each participant took a rimegepant tablet and reported their pain levels every 30 minutes. The main goal was to see how many people achieved pain relief within two hours. Results showed that many participants found relief from their migraines consistently. About 27.7% of participants suffered from chronic migraines, and most were women. The study also monitored safety and tolerability of the medication. Overall, rimegepant was effective for treating multiple migraine attacks, showing promising results in real-world settings. This research adds to the understanding of rimegepant's effectiveness for those who frequently experience migraines. Clinical relevance: This study demonstrates that rimegepant effectively relieves pain in multiple migraine attacks, providing valuable treatment options for patients suffering from frequent migraines.